Factor-sparing use of the COX-2 inhibitor rofecoxib in haemophilic arthropathy

Haemophilia. 2002 Nov;8(6):832-3. doi: 10.1046/j.1365-2516.2002.00683_2.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Cyclooxygenase 2
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors / therapeutic use*
  • Hemophilia A / complications*
  • Humans
  • Isoenzymes / antagonists & inhibitors*
  • Joint Diseases / drug therapy*
  • Lactones / therapeutic use*
  • Male
  • Membrane Proteins
  • Prostaglandin-Endoperoxide Synthases
  • Sulfones

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Cyclooxygenase 2 Inhibitors
  • Cyclooxygenase Inhibitors
  • Isoenzymes
  • Lactones
  • Membrane Proteins
  • Sulfones
  • rofecoxib
  • Cyclooxygenase 2
  • PTGS2 protein, human
  • Prostaglandin-Endoperoxide Synthases